Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) filed its Monthly Return for Equity Issuer for the period ended 31 March 2026, confirming that no changes occurred in either its authorised or issued share capital during the month.

• Authorised share capital remained at 10.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 100.00 million.

• Issued share capital was unchanged at 720.00 million ordinary shares; the company holds no treasury shares.

• No share options, warrants, convertible securities, or other share-issuance arrangements were outstanding or exercised during the month.

• The company affirmed that it met the Hong Kong Main Board’s minimum 25% public-float requirement as of 31 March 2026.

The filing was submitted on 1 April 2026 and signed by Executive Director Zhang Hongli.